SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Biotechnology
Biotechnology
Health
23andMe users are being urged to delete their data. Here’s how to do it
By
Alexa Mikhail
and
Beth Greenfield
March 24, 2025
Commentary
My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup
By
Michelle Werner
March 10, 2025
Leadership
A few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million
By
Lila MacLellan
March 1, 2025
Health
Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
By
Lindsey Leake
January 16, 2025
Aging Well
Arnold Schwarzenegger is joining a Fortune 500 company to solve a great problem of his generation
By
Lindsey Leake
November 13, 2024
Health
How to delete your DNA data from 23andMe
By
Alexa Mikhail
October 5, 2024
Tech
Meta axed his AI biology research team. Now this ‘Meta AI mafia’ member’s new startup has $142 million to chase his protein-generating dream
By
Sharon Goldman
June 25, 2024
Commentary
I’ve been practicing medicine at a renowned institution for 40 years. Society isn’t ready for us to reverse the aging process across an entire population
By
Joel Geiderman
June 20, 2024
Life
A 45-year-old tech CEO is spending millions a year to be 18 again—even though his doctor admits the results are minimal
By
Alexa Mikhail
January 26, 2023
Finance
Biden’s new executive order triggers new front in U.S.-China economic competition
By
Tristan Bove
September 12, 2022
Newsletters
At financial software giant Intuit, A.I. is becoming ‘foundational’ to how the company operates
By
Jeremy Kahn
August 26, 2022
Newsletters
A.I. is rapidly transforming biological research—with big implications for everything from drug discovery to agriculture to sustainability
By
Jeremy Kahn
July 28, 2022
Magazine
Moderna’s COVID vaccine success made the stock a big pandemic winner. Will the run continue?
By
Rey Mashayekhi
December 2, 2021
Newsletters
What’s big in A.I. this year
By
Jeremy Kahn
October 12, 2021
Tech
DeepMind unveils how it solved a 50-year-old scientific challenge that could speed drug discovery
By
Jeremy Kahn
July 15, 2021
Most Popular
Success
Multimillion-dollar restaurant CEO used to splurge on Range Rovers and McLarens—but he’s reining it in now because...
By
Emma Burleigh
Success
Millionaire Alexis Ohanian walked out of the LSAT 20 minutes in, went to a Waffle House, and decided he was ‘gonna...
By
Preston Fore
Tech
‘Yes, you read that correctly’: Tesla pay committee pitches $1 trillion pact to keep Elon Musk as CEO for long term
By
Nick Lichtenberg